Abevmy 100mg Bevacizumab Injection

Abevmy 100mg Bevacizumab Injection is a targeted anti-cancer medication containing Bevacizumab, a monoclonal antibody used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It works by blocking vascular endothelial growth factor (VEGF), a protein that promotes the development of new blood vessels that tumors need to grow and spread. By reducing the blood supply to cancer cells, Abevmy 100mg Bevacizumab Injection helps slow tumor progression and supports effective cancer management. Administered as an intravenous infusion under the supervision of an oncology specialist, it is often used in combination with chemotherapy or other cancer treatments. Regular medical monitoring is essential during therapy to assess treatment response and manage potential side effects. Patients should use Abevmy 100mg Injection only as directed by their healthcare provider.